Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Northmenon Dec 21, 2021 7:25am
309 Views
Post# 34249503

Aristotle Test

Aristotle TestFYI - I am a Cancer Survivor (7x times - 6 surgeries & 1 Chemo). As a result, I follow up with Dr's and Testing on a yearly basis. Obviousily ARISTOTLE caught my attention. 

I sent an email and received the following response within 1 day ( Your reservation to speak with an AVRT Case Manager is confirmed)

I scheduled a conference call at my convience with (Adrienne avrt@careoncology.com) who provided great information and the following quote: ( Attached is a brochure with information on our Aristotle blood test that you could present to your insurance company. The cost of the blood draw (which includes the meeting with the doctor for results) is $1495 in US dollars)

The quick response and Customer Service was very impressive

I am fortunate enough to have 2 seperate health insurances (Canada Life and Sun Life). Subsuquently the Quote and supplied Brochure have been sent to the above companies for Pre-Determination Approval

Once a response is received, I will advise accordingly

Full Disclosure - I am a Shareholder and also hope that the SP will rise ! More importantly, I pray that this technology can save lives and Pro-Actively detect or treat Cancer. GLTA      

<< Previous
Bullboard Posts
Next >>